Crohn's disease moxibustion

Effect of smokeless electronic moxibustion on intermittent abdominal discomfort of Crohn's disease in remission (pilot study)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001357

Enrollment

Registered

2015-01-27

Start date

2015-02-02

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Treatment : 3 times per week, total 4 week period Moxibustion point : both S-25, SP-15, single CV-4, CV-6, CV10. CV12 total 8 points. time: 20 minutes Moxibustion : electronic smok

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria ?those who are under treatment diagnosed Crohn' disease. ?those whose CDAI (Crohn's disease activity index) are 150 degree or less. ?those who have no medicine change during recent 3 months. ?those who provided written informed consent. voluntarily ?those who are capable of participating in follow up observations during the trial. ?those who aged 18 to 65 years old

Exclusion criteria

Exclusion criteria: Exclusion criteria ? those who've got other acupuncture or moxibustion recent 3 months ago ? those whose prednisolone prescription amount is over 15mg per day until 4 weeks before this trial. ? those who needed modificated prescription related with aggravated Crohn's disease ? those who are deemed inappropriate by a physician ? those who don't provide informed consent

Design outcomes

Primary

Measure	Time frame
Harvey-Bradshaw Index	—

Secondary

Measure	Time frame
VAS of abdominal discomfort ;Safety	—

Countries

Korea, Republic of

Contacts

Public ContactMinah Kwak

Daegu Oriental Hospital of Daegu Haany University

nari003@hanmail.net+82-53-650-3434

Outcome results